DXCM Financial Facts
Selling, general and administrative: 75.7MProduct cost of sales: 47.5M
See Full Income Statement
Commitments and contingencies (Note 4): 0
Cash and cash equivalents: 97.7M
See Full Balance Sheet
DexCom, Inc. (DXCM) Earnings
|
Expand Research on DXCM
Next EPS Date | 7/25/24 *Est. | EPS Growth Rate | +88.2% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | +32.4% | Revenue Growth Rate | +24.2% *Last Qtr. |
Average % Move 1-Wk after EPS | +0.7% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/4/10 | Q310 | -$0.23 | -$0.18 | -$0.05 | N/A | N/A | N/A | Details | |||
3/3/11 | Q410 | -$0.16 | -$0.19 | +$0.03 | $15.6M | $14.69M | N/A | Details | |||
5/3/11 | Q111 | -$0.19 | -$0.19 | $0.00 | $14.2M | $14.53M | N/A | Details | |||
8/3/11 | Q211 | -$0.11 | -$0.12 | +$0.01 | $21.4M | $20.83M | N/A | Details | |||
11/2/11 | Q311 | -$0.20 | -$0.16 | -$0.04 | $18.3M | $19.05M | N/A | Details | |||
2/23/12 | Q411 | -$0.18 | -$0.17 | -$0.01 | $22.4M | $21.63M | N/A | Details | |||
5/2/12 | Q112 | -$0.21 | -$0.19 | -$0.02 | $20.1M | $19.88M | N/A | Details | |||
8/6/12 | Q212 | -$0.21 | -$0.20 | -$0.01 | $23.5M | $22.24M | N/A | Details |